Table 3.
Risk factor | RR | P value |
---|---|---|
>3 days set use with lispro | 1.71 (1.03–2.85) | 0.07 |
Insulin analog use, any duration | ||
Lispro | 1.39 (0.95–2.10) | 0.12 |
Aspart | 0.76 (0.51–1.13) | 0.27 |
Glulisine | 0.62 (0.12–3.12) | 0.60 |
Kinking | 1.36 (0.89–2.10) | 0.17 |
Teflon cannula use | 0.76 (0.51–1.12) | 0.28 |
RR, relative risk.